New York, NY – In 2022, one out of every 10 employees belong to a Union. In the U.S., 34-percent of missed work days are related to musculoskeletal (MSK) pain, and working through pain is responsible for 40-percent of reduced productivity. When it comes to MSK, which affects 50-percent of American adults with an estimated higher propensity in Unionized workers, it’s critical that Funds take an innovative approach — one that is determined to reduce spending, while offering better care than the in-person standard. Today, Labor Unions are bargaining for convenient care options, and virtual solutions are on top of the list. However, it’s critical that Funds aim for solutions that also manage and promote health care savings. 

Since 2020, demand for virtual solutions to treat musculoskeletal (MSK) pain has skyrocketed.

How can they do it? By making clinical-grade care a convenience.

Since 2020, demand for virtual solutions to treat musculoskeletal (MSK) pain has skyrocketed. The pandemic exacerbated the demand for front-line care, making MSK pain more prevalent than ever before. SWORD Health’s comprehensive virtual physical therapy solution pairs members with a Doctor of Physical Therapy, a set of FDA-listed wearable motion sensors, and a tablet that provides them with a dynamic therapeutic exercise program. By cutting out travel and appointments, SWORD bridges a gap in adherence, giving members the chance to find relief anywhere — whether at home or on the job. With SWORD, Fund members are carefully monitored and have access to a licensed Doctor of Physical Therapy, who analyzes their biofeedback and results, and makes tailored adjustments to their program ongoing.

SWORD is the only solution clinically proven to outperform traditional physical therapy. Whether preventing surgery, or addressing chronic, acute, and post-surgical conditions, SWORD’s clinical-grade solution will help Fund members find relief for any MSK-related conditions of the lower back, shoulder, neck, knee, elbow, hip, ankle, and wrist. In doing so, Funds can anticipate a 34 percent-plus reduction in musculoskeletal-related costs.

Contact for more information.


Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Join Our Newsletter Today